Calmann Melissa A, Nowosielska Anetta, Marinus M G
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School 364 Plantation Street, Worcester, MA 01605, USA.
Nucleic Acids Res. 2005 Feb 24;33(4):1193-200. doi: 10.1093/nar/gki263. Print 2005.
DNA mismatch repair in Escherichia coli has been shown to be involved in two distinct processes: mutation avoidance, which removes potential mutations arising as replication errors, and antirecombination which prevents recombination between related, but not identical (homeologous), DNA sequences. We show that cells with the mutSDelta800 mutation (which removes the C-terminal 53 amino acids of MutS) on a multicopy plasmid are proficient for mutation avoidance. In interspecies genetic crosses, however, recipients with the mutSDelta800 mutation show increased recombination by up to 280-fold relative to mutS+. The MutSDelta800 protein binds to O6-methylguanine mismatches but not to intrastrand platinated GG cross-links, explaining why dam bacteria with the mutSDelta800 mutation are resistant to cisplatin, but not MNNG, toxicity. The results indicate that the C-terminal end of MutS is necessary for antirecombination and cisplatin sensitization, but less significant for mutation avoidance. The inability of MutSDelta800 to form tetramers may indicate that these are the active form of MutS.
大肠杆菌中的DNA错配修复已被证明参与两个不同的过程:避免突变,即消除复制错误产生的潜在突变;抗重组,即防止相关但不相同(异源)的DNA序列之间发生重组。我们发现,携带多拷贝质粒上mutSDelta800突变(去除MutS的C末端53个氨基酸)的细胞在避免突变方面表现正常。然而,在种间遗传杂交中,携带mutSDelta800突变的受体相对于mutS+显示出高达280倍的重组增加。MutSDelta800蛋白能结合O6-甲基鸟嘌呤错配,但不能结合链内铂化的GG交联,这解释了携带mutSDelta800突变的dam细菌对顺铂有抗性,但对MNNG毒性没有抗性的原因。结果表明,MutS的C末端对于抗重组和顺铂致敏是必需的,但对避免突变的重要性较低。MutSDelta800无法形成四聚体可能表明这些是MutS的活性形式。